RSNA2012 オススメ演題@堀越浩幸先生(群馬県立がんセンター)

RSNA2012 Report:オススメ演題
2012.11.12

RSNA2012「オススメ演題」について
堀越浩幸先生(群馬県立がんセンター)にお答えいただきました。

 
被曝低減に関する演題
CODE: SSA06-01
Scientific Formal (Paper) Presentations
Liver CT: Image Quality, Diagnostic Accuracy, and Potential for Radiation Dose Reduction Using a Model-based Iterative Reconstruction Technique; Comparison with Filtered Back Projection in Patients with Liver Metastases
Won Chang MD et al

DATE: Sunday, November 25 2012
TIME: 10:45-10:55 AM
LOCATION: E353A
●PURPOSE
To assess the radiation dose reduction, noise suppression, and image quality of half-dose liver CT using a model based iterative reconstruction algorithm (MBIR) compared to filtered back projection (FBP).
 
CODE: SSA06-07
Scientific Formal (Paper) Presentations
Performance of Low Dose Abdomen CT Images Reconstructed with Sinogram Affirmed Iterative Reconstruction (SAFIRE) and Filtered Back Projection(FBP)
Gaurav Desai MBBS et al

DATE: Sunday, November 25 2012
TIME: 11:45-11:55 AM
LOCATION: E353A
●PURPOSE
To compare image quality of low dose Abdomen CT using SAFIRE and FBP and standard dose FBP images.• To determine the SAFIRE level that is considered optimal for image quality.
 
CODE: SSA06-08
Scientific Formal (Paper) Presentations
Liver CT Image Quality Improvement Using Adaptive Iterative Dose Reduction (AIDR), Three-dimensional (3D) Integrated Dose Navigation on 320-detector CT
Jeong Hee Yoon MD et al

DATE: Sunday, November 25 2012
TIME: 11:55-12:05 PM
LOCATION: E353A
●PURPOSE
To evaluate the impact of 3), Adaptive Iterative Dose Reduction (AIDR) on the image quality and radiation dose compared with filtered back projection (FBP) in liver CT scanning using a 320-detector row MDCT scanner, and to demonstrate the technical feasibility of 3D AIDR integrated dose navigation for radiation dose reduction.
 
副腎の鑑別診断について
CODE: SSA09-09
Scientific Formal (Paper) Presentations
Characterization of Incidental Adrenal Lesions by Means of Computed Tomography: Comparison Between 5 and 15 Minutes Delayed Scans for Differentiating Adrenal Adenomas from Nonadenomas
Giovanni Foti MD et al

DATE: Sunday, November 25 2012
TIME: 12:05-12:15 PM
LOCATION: E351
●PURPOSE
To evaluate the diagnostic accuracy of multi-detector computed tomography (MDCT) in characterizing incidental adrenal lesions, comparing 5 versus 15 minutes delayed scan for the measurement of wash-out parameters.
 
USの検診について
CODE:LL-BRS-SU3A
Scientific Informal (Poster) Presentations
Initial Results: Integration of Automated 3D Breast Ultrasound (ABUS) into the Routine Workflow of a High-Volume Hospital-based Breast Cancer Screening Program in Stockholm, Sweden
Karin Leifland MD et al

DATE: Sunday, November 25 2012
TIME: 12:30-01:00 PM
●PURPOSE
To evaluate recall, biopsy and cancer detection rates for the combination of full-field digital mammography (FFDM) and ABUS, compared to FFDM alone.
 
個人的に興味あります
CODE: VSIO11-04
Scientific Formal (Paper) Presentations
Uptake of Gadoxetic Acid as a New Prognostic Factor for Local Recurrence after Chemoembolization of Hepatocellular Carcinoma
Hideki Ishimaru MD et al

DATE: Sunday, November 25 2012
TIME: 02:20-02:30 PM
LOCATION: S405AB
●PURPOSE
Organic anion transporter 8 (OATP8) responsible for hepatocellular uptake of drugs is down-regulated in usual hepatocellular carcinomas (HCCs), which causes low enhancement in gadoxetic acid-enhanced MR imaging. The down-regulation of OATP8 is also supposed to affect uptake of anticancer drugs, causing chemoresistance of HCCs. Some HCCs overexpress OATP8 and show high uptake of gadoxetic acid; the overexpression might influence chemotherapeutic effect.We aimed to investigate whether HCCs showing high uptake of gadoxetic acid are more susceptible to transarterial chemoembolization (TACE).
 
MRI/PETの演題から
CODE: VSGU21-03
Scientific Formal (Paper) Presentations
Hybrid PET/MRI Improves the Detection of Prostate Cancer in the Peripheral
Zone
Thomas De Perrot et al

DATE: Monday, November 26 2012
TIME: 09:10-09:20 AM
LOCATION: N228
●PURPOSE
To define the benefit of using a18F-fluorocholine whole-body PET-MRI combined in a single session with pelvic MRI on a 3 Tesla PET-MRI scanner for prostate cancer detection in patients scheduled for a radical prostatectomy.
 
CODE: SSC04-01
Scientific Formal (Paper) Presentations
Preoperative Staging of Non-Small Cell Lung Cancer with Coregistered Whole Body MRI-PET: A Prospective Randomized Controlled Trial
Chin A Yi MD, PhD et al

DATE: Monday, November 26 2012
TIME: 10:30-10:40 AM
LOCATION: S404CD
●PURPOSE
Currently PET-CT plus brain MRI is considered the general method of lung cancer staging. However, upcoming simultaneously acquired whole body MRI-PET is expected to be the future way of accurate staging in patients with non-small cell lung cancer (NSCLC). The purpose of this randomized controlled study was to assess whether coregistered whole body MRI-PET correctly helps upstage lung cancer status in more patients with NSCLC than dose PET-CT plus brain MRI.
 
CODE: SSC13-04
Scientific Formal (Paper) Presentations
Contrast-enhanced PET/CT vs Non-Contrast Enhanced PET/MRI in Abdominal Oncological Lesions Osteopathy-Initial Results
Yasser Assiri MD et al

DATE: Monday, November 26 2012
TIME: 11:00-11:10 AM
LOCATION: S505AB
●PURPOSE
PET/MRI has to measure up to PET/CT and should ideally show diagnostic advantages over PET/CT before introduction into clinical routine. The purpose was to compare contrast-enhanced PET/CT (cePET/CT) and non contrast-enhanced PET/MRI (PET/MRI) concerning diagnostic accuracy in evaluation of abdominal lesions.
 
CODE: SSC13-02
SESSION: SSC13
Simultaneous PET/MR Imaging in Gynecologic Malignancies: Initial Clinical Images and Comparison with PET/CT
Maria Thomas MD, PhD et al

DATE: Monday, November 26 2012
TIME: 10:40-10:50 AM
LOCATION: S505AB
●PURPOSE
To evaluate the clinical utility of simultaneous acquisition of PET and MR imaging in patients with gynecologic malignancies and to compare PET/MR images with those obtained with PET/CT.
 
肺領域から
CODE: LL-CHS-MO4A
Scientific Informal (Poster) Presentations
Usefulness of Half-Fourier Acquisition Single-Shot Turbo Spin-Echo (HASTE) in Evaluation of Local Invasion of Lung Cancer
Suyon Chang MD et al

DATE: Monday, November 26 2012
TIME: 12:15-12:45 PM
LOCATION: Lakeside Learning Center
●PURPOSE
Recently, Half Fourier Single Shot Turbo Spin-Echo (HASTE) imaging with short TE and short inter-echo spacing, has found increased use in lung imaging. The features of HASTE include fast imaging, little motion artifacts, high signal intensity of the fat, and by using parallel imaging, margin blurring can be reduced. Therefore in this study, we evaluated the usefulness of HASTE alone for the evaluation of local tumor invasion of lung cancer.
 
CODE: VSIO21-08
SESSION: VSIO21
Whole-Body 3T MRI with and without Newly Developed Quick 3D and Double Fat Suppression Techniques vs FDG-PET/CT vs. Conventional Radiological Method: Capability for Postoperative Recurrence Assessments in Non-Small Cell Lung Cancer
Yoshiharu Ohno MD, PhD et al

DATE: Monday, November 26 2012
TIME: 02:55-03:05 PM
LOCATION: S405AB
●PURPOSE
To compare the capability for assessment of postoperative recurrence in non-small cell lung cancer (NSCLC) patients among whole-body MRI at 3T system with and without newly developed quick segmented 3D T1-weighted gradient echo sequence (Quick 3D) and a double fat suppression (DFS) technique for enhancing fat free capability (WB-MRI with and without Quick 3D and DFS), FDG-PET/CT and conventional radiological method.
 
CODE: VSCH31-12
Scientific Formal (Paper) Presentations
PET/MR in Non-small Cell Lung Cancer: Initial Experience
Ivan Platzek MD et al

DATE: Tuesday, November 27 2012
TIME: 11:00-11:10 AM
LOCATION: N230
●PURPOSE
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG), mostly performed in combination with computed tomography (CT) as PET/CT, plays a fundamental role in the staging of non-small lung cancer (NSCLC). The aim of this pilot study was to evaluate the feasibility of PET combined with magnetic resonance imaging (PET/MR) for initial staging of NSCLC.
 
CODE: VSCH31-06
SESSION: VSCH31
Epidermal Growth Factor Receptor (EGFR) Mutation in Lung Adenocarcinoma: Its Relation with CT, PET/CT and Diffusion-weighted MRI Findings
Miyeon Yie et al

DATE: Tuesday, November 27 2012
TIME: 09:30-09:40 AM
LOCATION: N230
●PURPOSE
Several studies showed that EGFR mutations are related with adenocarcinoma in situ (AIS, for bronchioloalveolarcarcinoma [BAC]) component on histopathology and the proportion of ground-glass opacity (GGO) within whole tumor at CT as well. Moreover, it has been known that apparent diffusion coefficient (ADC) value at MR imaging in lung adenocarcinomas with high proportion of AIS component is higher than adenocarcinoma without AIS component. The purpose of this study was to evaluate interrelationship between the presence of EGFR mutation in lung adenocarcinomas and ADC value at MR imaging, maximal SUV (standardized uptake values, SUVmax) at PET/CT, or GGO extent within the tumor at CT.
 
同じ条件で撮影しているので気になります
CODE: VSBR51-02
Scientific Formal (Paper) Presentations
Automated Evaluation of an Ultrafast MR Imaging Protocol for the Characterization of Breast Lesions
Bram Platel PhD et al

DATE: Thursday, November 29 2012
TIME: 08:50-09:00 AM
LOCATION: E450A
●PURPOSE
To investigate the potential of a novel, ultrafast, high-spatial resolution MR imaging sequence that images for only 100 sec. -starting with contrast agent (CA) injection- for the characterization of breast lesions, using automated analysis.